In this study, we aim to dissect the underlying mechanisms of the ABCC4-PGE2 axis in orchestrating the functional impairment of infiltrating CD8+ T cells in prostate cancer, while concurrently unraveling the metabolic perturbations characteristic of prostate cancer that contribute to immune suppression. Here, CD8A is linked to prostate carcinoma.